Chikungunya Invest Information

Companies
Valneva Seeks to Extend Use of Chikungunya Vaccine with Label Extension Submissions Sep 19, 2024
Pharmaceuticals
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications Sep 18, 2024
Companies
Valneva's Innovative IXCHIQ® Becomes the First Chikungunya Vaccine Authorized in Europe Jul 1, 2024
Pharmaceuticals
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva Nov 10, 2023
Stocks
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises Nov 10, 2023